TNF Pharmaceuticals Faces Delisting Concerns
Ticker: QCLS · Form: 8-K · Filed: Mar 21, 2025 · CIK: 1321834
| Field | Detail |
|---|---|
| Company | Tnf Pharmaceuticals, Inc. (QCLS) |
| Form Type | 8-K |
| Filed Date | Mar 21, 2025 |
| Risk Level | high |
| Sentiment | bearish |
Sentiment: bearish
Topics: delisting, compliance, regulatory
TL;DR
TNF Pharma might get kicked off the exchange - big trouble.
AI Summary
TNF Pharmaceuticals, Inc. (formerly MyMD Pharmaceuticals, Inc.) filed an 8-K on March 21, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the earliest event date being March 17, 2025. The company, incorporated in Delaware, is involved in diagnostic substances.
Why It Matters
This filing indicates potential issues with TNF Pharmaceuticals' compliance with stock exchange listing requirements, which could lead to its shares being delisted.
Risk Assessment
Risk Level: high — A notice of delisting directly threatens the company's ability to remain publicly traded, posing a significant risk to investors.
Key Players & Entities
- TNF Pharmaceuticals, Inc. (company) — Registrant
- MyMD Pharmaceuticals, Inc. (company) — Former company name
- Akers Biosciences, Inc. (company) — Former company name
- March 17, 2025 (date) — Earliest event date
- March 21, 2025 (date) — Filing date
FAQ
What specific listing rule or standard has TNF Pharmaceuticals failed to satisfy?
The filing does not specify the exact rule or standard that TNF Pharmaceuticals has failed to satisfy, only that a notice of delisting or failure to satisfy a continued listing rule or standard has been issued.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing occurred on March 17, 2025.
What is the current filing date for this 8-K report?
This 8-K report was filed on March 21, 2025.
What were TNF Pharmaceuticals, Inc.'s previous names?
TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and Akers Biosciences, Inc.
What is the Standard Industrial Classification (SIC) code for TNF Pharmaceuticals, Inc.?
The Standard Industrial Classification (SIC) code for TNF Pharmaceuticals, Inc. is 2835, which corresponds to IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on March 21, 2025 regarding TNF Pharmaceuticals, Inc. (QCLS).